Patents by Inventor Andreas Draguhn

Andreas Draguhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150079096
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: October 14, 2014
    Publication date: March 19, 2015
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christiane Grimm, Carsten Krantz
  • Patent number: 8895004
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: November 25, 2014
    Assignee: AbbVie Deutschland GmbH & Co. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christine Grimm, Carsten Krantz
  • Publication number: 20110130549
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an inhibitor of the interaction between A? globulomer and the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: February 27, 2008
    Publication date: June 2, 2011
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruehl, Christiane Grimm, Carsten Krantz
  • Publication number: 20100311767
    Abstract: The present invention relates to a method for the treatment of an amyloidosis such as Alzheimer's disease in a subject in need thereof, characterized in that it comprises administering an agonist of the P/Q type voltage-gated presynaptic calcium channel to said subject.
    Type: Application
    Filed: February 27, 2008
    Publication date: December 9, 2010
    Applicant: ABBOTT GMBH & CO. KG
    Inventors: Volker Nimmrich, Stefan Barghorn, Ulrich Ebert, Heinz Hillen, Gerhard Gross, Andreas Draguhn, Claus Bruhl, Christine Grimm, Carsten Krantz